POC NAME | MEASURED PARAMETERS | TEST TIME | IMPRECISION | ACCURACY |
---|---|---|---|---|
INSTITM (bioLytical Laboratories, Richmond BC) [176, 177] | HIV-1/2 antibodies | 10 minutes | N/A | r = 0.99 |
MBioTM (MBio Diagnostics, USA) [178] | CD4 count | 10 minutes | CV = 8.1% | r = 0.97 |
VISITECT® (Omega Diagnostics Ltd, Scotland, UK) [179] | CD4 count | 40 minutes | CV = 15% | r = 0.98 |
Alere q 1/2 Detect (Alere Healthcare, Waltham, Massachusetts, USA) [180-182] | HIV nucleic acids | 56 minutes | CV = 5.58% | r = 0.99 |
Cobas® Liat® system (Roche Molecular Systems, Pleasanton, USA) [183-186] |
Influenza A/B nucleic acid | 20 minutes | CV = 0.9 - 2.9% | r = 0.98 |
SAMBA I and II (Diagnostics for the Real World Ltd., Cambridge, UK) [187, 188] | HIV-1 nucleic acid | 90 minutes | N/A | r = 0.99 |
OraQuick ADVANCE® (OraSure Technologies, Inc., Bethlehem, USA) [189-191] | HIV-1/2 antibodies | 20 minutes | N/A | N/A |
Dual Path Platform (Chembio Diagnostic Systems, Inc, Medford, NY, USA) [192-194] | HIV/HCV Antibody | 15 - 25 minutes | CV = 0.47% | N/A |
SD Bioline (Standard Diagnostics Yongin, Korea) [195] | anti-HCV antibody | 5 minutes | CV = 0% | r = 0.83 |
Bioeasy® (Bioeasy Diagno´stica, Belo Horizonte, Minas Gerais, Brazil) [196, 197] | anti-HCV antibody | 10-15 minutes | N/A | N/A |
Hexagon® (Human Diagnostics Worldwide, Wiesbaden, Germany) [198, 199] |
anti-HCV antibody | 5-20 minutes | N/A | N/A |
Genedia® Rapid LF (Green Cross Medical Science, Yongin, Korea) [200] | anti-HCV antibody | 20-30 minutes | N/A | r = 0.83 |
Diagnos® Bi-Dot (Mitra, New Delhi, India) [198] | anti-HCV antibody | 3 minutes | CV < 20% | N/A |
HCV Spot® (MP Biomedicals, Santa Ana, California, USA) [201] | anti-HCV antibody | 2 minutes | N/A | r = 0.93 |
SM-HCV (SERO-Med, Germany) [202] | anti-HCV antibody | 10 minutes | N/A | N/A |
Ab rapid test (Tema Ricerca, Italy) [203] | anti-HCV antibody | < 3 minutes | N/A | N/A |
Orthopox® Bio Threat Alert assay (Tetracore, USA) [204] | anti-OPV antibody | 15 minutes | N/A | N/A |
Clearview® Exact Influenza A+B (Alere, USA) [205, 206] | influenza A and B nucleoprotein antigens | 15 minutes | N/A | N/A |
Directigen® EZ Flu A+B (Becton, Dickinson, & Co. Diagnostics, USA) [207-209] | influenza A and B nucleoprotein antigens | 15 minutes | CV = 4 - 4.5% | r = 0.78 |
QuickVue® Influenza A+B (Quidel Corp, USA) [210, 211] | influenza A and B nucleoprotein antigens | 10 minutes | N/A | r = 0.81 |
3M Rapid Detection® Flu A+B (3M, USA) [212] | influenza A and B nucleoprotein antigens | 15 minutes | N/A | N/A |
OSOM® Influenza A&B (Sekisui Chemical Co. Ltd, Japan) [213] | influenza A and B nucleoprotein antigens | 10 minutes | N/A | r = 0.95 |
Influenzatop® (All.Diag, France) [214] | influenza A and B nucleoprotein antigens | 10 minutes | N/A | r = 0.78 |
Actim® Influenza A&B (Medix Biochemica, Finland) [215, 216] | influenza A and B nucleoprotein antigens | 10 minutes | N/A | r = 0.81 |
Influ-A&B Respi-Strip® (Coris BioConcept, Belgium) [216, 217] | influenza A and B nucleoprotein antigens | 15 minutes | N/A | r = 0.81 |
Quick® Ex-Flu/ Quick® S- Influ A/B (Denka Seiken Co Ltd, Japan) [216] | Detection of influenza A and B nucleoprotein antigens | 15 minutes | N/A | r = 0.86 |
Espline® Influenza A&B-N (Fujirebio, Japan) [205] | influenza A and B nucleoprotein antigens | 15 minutes | N/A | N/A |
Rockeby® Influenza A Antigen (Rockeby, Singapore) [218] | influenza A and B nucleoprotein antigens | 15 minutes | N/A | N/A |
Merlin® dengue (Merlin, Diagnostika GmbH, Bornheim, Germany) [219] | Dengue virus IgM antibody | 10 minutes | N/A | r = 0.79 |
Dengue Duo® (Standard Diagnostics, South Korea) [220, 221] | Dengue virus IgM antibody | 15-20 minutes | CV = 3% | r = 0.86 |
Biosynex® Immunoquick dengue (Biosynex, France) [219] | Dengue virus IgM antibody | 15 minutes | N/A | N/A |
Bio-Rad® NS1 antigen strip (Bio-Rad, France) [222] | Dengue virus IgA antibody | < 15 minutes | N/A | r = 0.77 |
Panbio® Dengue (Inverness, Australia) [222] | Dengue virus IgA antibody | 10-20 minutes | N/A | r = 0.66 |
Pima™ CD4 (Alere Inc, Waltham, MA, USA) [223, 224] | CD4 testing | 20 minutes | CV = 4.0 -17% | r = 0.89 |
Liat™ HIV Quant (Roche Molecular Systems, Inc., Branchburg, USA) [225] | HIV-1 nucleic acid | 30 minutes | CV = 1.8 - 2.7% | r = 0.96 |
GeneXpert® HIV-1 Quant (Cepheid Innovations Pvt. Ltd., USA) [226, 227] | HIV-1 nucleic acid | 90 minutes | CV = 3.52 - 4.15% | r = 0.88 |
Xpert® HIV-1 (Cepheid, Sunnyvale, USA) [228] | HIV-1 nucleic acid | 90 minutes | CV < 3% | r = 0.96 |
Dengue DAY 1 Test (J. Mitra & Co., India) [229] | NS1 antigen, IgM and IgG | 20 minutes | N/A | N/A |
Simplexa HSV1 & 2 Direct kit (DIASORIN MOLECULAR LLC, Cypress, USA) [230, 231] | HSV1 and HSV2 nucleic acids | 75 minutes | CV = 1.8 - 3.9% | r = 0.84 - 0.89 |
ReEBOV Antigen Rapid Test (Autoimmune Technologies, New Orleans, USA) [232, 233] | Ebola virus rVP40 antigen | 15–25 minutes | N/A | r = 0.96 |
Aeonose® (The eNose Company, Zutphen, The Netherlands) [234] |
viral infections in acute exacerbations of chronic obstructive pulmonary disease | 15 minutes | N/A | r = 0.74 |
i RSV test (Alere Inc. Waltham, USA) [235] | RSV nucleic acid | 13 minutes | N/A | N/A |
EBOLA Ag K-SeT (Coris BioConcept, Gembloux, BELGIUM) [236] | Ebola virus VP40 viral matrix protein | 15 minutes | N/A | N/A |
HIV Combo (Alere Inc. Waltham, USA) [237, 238] | HIV core protein p24 | 20 minutes | CV = 3.6 - 24.11% | r = 0.98 |
VIKIA® Rota-Adeno (bioMérieux, Marcy l’Etoile, France) [239] | rotavirus structural protein VP6 | 10 minutes | CV = 3.6 - 12.5% | r = 0.99 |
GeneXpert® (Cepheid, Sunnyvale, USA) [240] | MPXV nucleic acid | < 90 minutes | N/A | N/A |
FACSPresto (Becton Dickinson Biosciences, NJ, USA) [241, 242] | CD4 | 120 minutes | CV = 9.79% | r = 0.91 |